Microtubule dynamics is a therapeutic vulnerability in VHL-deficient renal cell carcinoma

Yue Pu1, Ziruoyu Wang2, Shishi Tao1,3

  • 1Cancer Centre, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China.

Insights

Von Hippel-Lindau (VHL) deficiency creates a vulnerability in renal cell carcinoma (RCC) that can be targeted. SKPin C1, a microtubule-disrupting agent, selectively kills VHL-deficient RCC cells by altering microtubule dynamics.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Von Hippel-Lindau (VHL) is a tumor suppressor gene frequently mutated in renal cell carcinoma (RCC).
  • Loss of VHL function is a potential therapeutic target in RCC.
  • Identifying synthetic lethal interactions in VHL-deficient RCC is crucial for developing novel treatments.

Purpose of the Study:

  • To identify therapeutic vulnerabilities in VHL-deficient RCC.
  • To investigate the mechanism of action of SKPin C1 in VHL-deficient RCC cells.
  • To explore the role of microtubule dynamics in VHL-deficient RCC.

Main Methods:

  • Screening of VHL-deficient RCC cells with SKPin C1, a SKP2 inhibitor.
  • Biochemical and molecular interaction studies to determine SKPin C1's binding targets.
  • Analysis of microtubule dynamics, spindle assembly, and cell death induction.
  • Assessment of GTP-tubulin and acetylated microtubule levels.

Main Results:

  • SKPin C1 exhibited synthetic lethal effects on VHL-deficient RCC cells, independent of SKP2 inhibition.
  • SKPin C1 selectively disrupted spindle assembly and induced mitotic arrest and death in VHL-deficient RCC.
  • SKPin C1 binds to tubulin and inhibits microtubule polymerization, with a more pronounced effect in VHL-deficient cells.
  • VHL loss alters microtubule dynamics, increasing growth speed and decreasing stability.
  • SKPin C1 and other microtubule destabilizers suppressed microtubule growth and reduced GTP-tubulin and acetylated microtubules in VHL-deficient RCC.

Conclusions:

  • Microtubule dynamics represent a therapeutic vulnerability in VHL-deficient RCC.
  • SKPin C1 selectively targets VHL-deficient RCC by disrupting microtubule dynamics.
  • Combination therapy of VHL-deficient RCC with anti-microtubule agents and targeted therapies is a promising strategy.

Related Concept Videos

Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
4.9K
Microtubules01:18

Microtubules

Microtubules are the thickest cytoskeletal filaments with a diameter of 25 nm. In prokaryotic organisms, microtubules are commonly found in locomotory appendages like cilia and flagella. In eukaryotic cells, microtubules form specialized extensions for moving fluid over the surface, like those found in cells lining the intestine.
Microtubules have two structurally similar globular protein subunits: α and β tubulins. In the cytosol, the α and β tubulins form a heterodimer....
7.0K
Microtubule Formation01:23

Microtubule Formation

Microtubules are dynamic structures that undergo continuous assembly and disassembly. They originate from specialized multi-protein complexes known as microtubule organizing centers or MTOCs. Within the MTOC, the point of origin of the microtubule is known as the minus end, while the end radiating outward is the plus end. Microtubules serve two primary functions — the organization of spindle complexes to separate sister chromatids during mitotic or meiotic cell division and the formation...
5.4K